Skip to content

Consumer perception for Rosemary hair oil

An Open Label Clinical Study to Assess the Dermatological Safety Efficacy and Consumer-Reported Outcomes of The Body Shop Rosemary hair oil in Healthy Adult male and female participants - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095452
Enrollment
30
Registered
2025-09-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: The Body Shop Rosemary hair oil B No TBSR0825: The Body shop Rosemary Hair Oil twice a week at night approximately 5 10 ml depending on the hair length The test product will be applied

Sponsors

Quest Retails private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy male & female participants in the age group of 18 55 years both age inclusive Participants having self perception of hair loss Participants having dull and dry hair Participants willing to give voluntary written informed consent Participants willing to apply Investigational Product & wash their hair twice in a week Participants do not use any hair regrowth product or medicine except test products for hair growth Participants whose screening hair fall count is minimum of 20 Participants having colored hair/ non colored hair in almost equal proportion If colored hair then the minimum time frame from coloring to screening is 2 to 3 weeks Participant is having apparently healthy skin on the test area and without any open wounds cuts abrasions irritation symptoms on the test area Participant willing to perform UPT Participant willing to give a written informed consent and come for regular observation

Exclusion criteria

Exclusion criteria: Participants who are undergoing hair growth treatment 3 months before starting the study Participants who have disorders like eczema scalp infection etc at the time of screening Participants who have treatments of actinotherapy or cancer chemotherapy within 6 months before starting study or have a plan to do treatments of them during study terms Participants who have hair transplant Participants with Known hypersensitivity to any of the study products or constituents Participant is Pregnant or Lactating Participants participated in any other cosmetic or therapeutic trial or in a similar investigation in the trial

Design outcomes

Primary

MeasureTime frame
hair strength and scalp & hair condition as well as consumer feedback on ease of use, sensory attributes, perceived benefits, satisfaction and willingness to continue or recommend the productTimepoint: Day 0 Day 20 Day 45

Secondary

MeasureTime frame
Safety and tolerabilityTimepoint: Day 0 Day 20 Day 45

Countries

India

Contacts

Public ContactDr Karishma Kapoor

Auriga Research Private Limited

karishma.kapoor@aurigaresearch.com09871953143

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026